Skip to main content

Table 1 The clinicopathologic characteristics of 1167 stage I-III colorectal cancer patients following radical resection

From: Factors affecting number of lymph nodes harvested and the impact of examining a minimum of 12 lymph nodes in stage I-III colorectal cancer patients: a retrospective single institution cohort study of 1167 consecutive patients

Variables

Number (%)

Gender

 

 Male/Female

691 (59.2)/476 (40.8)

Age (y/o)

 

65/<65

610 (52.3)/557 (47.7)

Maximum size (cm)

 

5/<5

414 (35.5)/753 (64.5)

Tumor location

 

 Colon/Rectum

797 (68.3)/370 (31.7)

Tumor stage

 

 I/II/III

302 (25.9)/425 (36.4)/440 (37.7)

T stage

 

 T1/T2/T3/T4

121 (10.4)/239 (20.5)/723 (61.9)/84 (7.2)

Harvested LN Noa

 

12/<12

807 (69.2)/360 (30.8)

Vascular invasion

 

 Yes/No

261 (22.4)/906 (77.6)

Perineural invasion

 

 Yes/No

303 (26.0)/864 (74.0)

Tumor grade

 

 WD/MD/PDb

96 (8.3)/969 (83.0)/102 (8.7)

Tumor histology

 

 A/M/Sc

1097 (94.0)/66 (5.7)/4 (0.3)

Preoperative CEAd (ng/ml)

 

5/<5

441 (35.2)/756 (64.8)

Type of surgery

 

 Open/Laparoscopic

967 (82.9)/200 (17.1)

  1. a LN No numbers of lymph nodes
  2. b WD well differentiated, MD moderately differentiated, PD poorly differentiated
  3. c A adenocarcinoma, M mucinous carcinoma, S signet-ring cell carcinoma
  4. d CEA carcinoembryonic antigen